你说的不对，复星一直都是敞开门卖的，是台湾不愿意采购，台湾觉得复星是大陆的总代理，从复星买就是从大陆买。
但是辉瑞也不肯直接销售给台湾，复星代理权包括了台湾。
这政治绕的，把小命绕进去了。
还有不可思议的印度。今天早上看到一个印度的视频，视频主说印度政府要割韭菜，也要让我们活着你才能割呀。这个时候还玩什么政治，到处都没氧气在死人。
上海复星确认，新华社背书，愿意给台湾辉瑞疫苗
- 主题发起人 安妹妹
- 开始时间
但是辉瑞也不肯直接销售给台湾，复星代理权包括了台湾。
这政治绕的，把小命绕进去了。
还有不可思议的印度。今天早上看到一个印度的视频，视频主说印度政府要割韭菜，也要让我们活着你才能割呀。这个时候还玩什么政治，到处都没氧气在死人。
gocanoeing
本站元老
- 注册
- 2006-11-21
- 消息
- 16,426
- 荣誉分数
- 2,386
- 声望点数
- 373
台湾卫生部长对此表示，都在放話也未見正式訊息
udn.com
台湾总统府发言人还在推特上说，中国阻碍台湾采购疫苗
不过台湾采购其他疫苗的时候是自己主动上门采购呢，还是坐等疫苗厂商到台湾申请？
感觉台湾一面对中国架子就端起来了，就算是和救命有关的事也要讲政治，如此的话似乎中国说过意思到了就行了，台湾是不是主动采购疫苗就随它了
上海復星願供BNT疫苗 陳時中：都在放話也未見正式訊息 | 聯合新聞網：最懂你的新聞網站
我國疫情不斷延燒，第三批AZ疫苗抵台，三批累計約72多萬劑，但即使全面接種也難達覆蓋率。上海復星醫藥集團表示，願意將擁有...
台湾总统府发言人还在推特上说，中国阻碍台湾采购疫苗
不过台湾采购其他疫苗的时候是自己主动上门采购呢，还是坐等疫苗厂商到台湾申请？
感觉台湾一面对中国架子就端起来了，就算是和救命有关的事也要讲政治，如此的话似乎中国说过意思到了就行了，台湾是不是主动采购疫苗就随它了
- 注册
- 2005-11-23
- 消息
- 30,321
- 荣誉分数
- 7,459
- 声望点数
- 373
CNN报道台湾指责大陆阻扰它获得疫苗，实据情况很复杂。谁在搞政治？
台湾订了2千万剂疫苗，足够免疫43%人口，现在只到货70万，全部是AZ。
民众对疫苗表现出Low Interest。
台湾事实上的美国驻华大使萧说，由于台湾对疫苗的需求最初很低，她一直致力于帮助台北的邦交国获得疫苗。 但据CNA称，现在她正在努力确保台湾的订单能按时交付。
台北以台湾法律禁止进口供人类使用的中国疫苗为由，完全拒绝接受北京生产的中国疫苗。
陈说，现在台湾很需要依靠外国疫苗来应对这场危机-但不是那些来自其最近邻国的，供应量最大的疫苗。
Taiwan blames China for slowing down its access to Covid-19 vaccines. The reality is more complicated
By Nectar Gan and Eric Cheung, CNN
Updated 9:53 PM ET, Fri May 21, 2021
(CNN)As countries ravaged by the coronavirus rushed to vaccinate their populations earlier this year, there was little sense of urgency to get inoculated in Taiwan.
The island of 23 million people had recorded close to zero local infections for months, and demand for the vaccine was so low that only 1% of the population was vaccinated.
But in this pandemic things can change quickly. Today, Taiwan is battling its worst outbreak yet, reporting more than 1,000 new cases in the past week, and has a population that wants the vaccine -- but can't get it.
Now, the Taiwanese government is asking the United States for a share of the shots President Joe Biden plans to send abroad, as it waits for other deliveries to arrive.
But in theory, there could be a solution for Taiwan right on its doorstep: Chinese vaccines.
China has sent tens of millions doses of its domestically developed vaccines around the world. But tensions across the Taiwan Strait have run high since the pandemic, with Beijing blocking Taiwan's participation at the World Health Organization, courting Taipei's dwindling allies and ramping up military pressure on the self-governed island, which it considers part of its territory.
Taiwan was a Covid success story. Now it's fighting its biggest outbreak
Amid growing hostility and distrust, Taipei has outright refused to accept Chinese-made vaccines from Beijing, citing Taiwanese law banning the import of Chinese vaccines for human use. That's a move Beijing has blasted as tantamount to "sacrificing people's well-being for its own political interests."
Taipei doesn't see it that way, and has accused Beijing of blocking its supply, rather than trying to boost it.
On Wednesday, Presidential Office spokeswoman Kolas Yotaka said on Twitter: "Taiwan access to vaccines continues to be slowed down by Chinese interference, while they insist we buy Chinese made ones. If you really want to help please don't stand in the doorway, don't block up the hall."
Yotaka did not offer details on alleged Chinese interference. But in February, the island's Health Minister Chen Shih-chung revealed in a radio interview that Taiwan and BioNTech were about to sign a contract for 5 million vaccine doses in December, until the deal fell through due to "political pressure." While BioNTech has a distribution deal in greater China with the Shanghai-based firm Fosun Pharma, Beijing denies obstructing the Taiwan deal.
But as a war of words around vaccines rages on, the reality is Taiwan's slow vaccine rollout goes far deeper than geopolitical tensions with China.
According to the island's official Central News Agency (CNA), Taiwan signed a deal with AstraZeneca last year to purchase 10 million doses of its vaccine. In March, 117,000 doses were finally shipped from a South Korean factory, becoming the first vaccines to arrive on the island.
Taiwan blames 'external forces' for blocking BioNTech vaccine deal. China says it had nothing to do with it
Taiwan also ordered 4.76 million doses through COVAX -- the global initiative backed by WHO to ensure equitable access to Covid-19 vaccines. The first batch of 199,200 shots arrived in early April, followed by a second delivery of 400,000 doses on Wednesday.
In February, Taiwan signed a contract for 5 million doses with US vaccine maker Moderna. The island's Central Epidemic Command Center said the shots were expected to be delivered this month. Last week, Taipei's top official in Washington said the shipment is now scheduled to arrive in June, CNA reported.
Hsiao Bi-khim, Taiwan's de-facto ambassador to the US, said as demand for vaccines in Taiwan was initially low, she had focused on helping Taipei's diplomatic allies secure vaccines. But now she is working to ensure Taiwan's orders are delivered on time, according to CNA.
In mid-April, it allowed people outside the government's priority list to be vaccinated at a cost of 600 New Taiwan dollars ($21) per shot.
But interest in taking the vaccine was low, as people had been enjoying a largely normal life for months, going to bars, restaurants, concerts and baseball games. There were also concerns about side effects, amid reports of blood clots in people who had received the AstraZeneca vaccine.
"Over the last 1.5 years, Taiwan did not experience a major outbreak, so many residents did not feel they were in any immediate danger," said Chen Hsiu-hsi, an epidemiology professor at National Taiwan University. "This is why not many people had the incentive to take Covid-19 vaccines."
But the spike in cases this month has caused alarm, prompting some residents to rush to get vaccinated. Before the latest batch from COVAX arrived on Wednesday, Taiwan had used up two-thirds of its 300,000-dose vaccine supply.
As supplies run short, the Taiwanese government has suspended the paid-for program, reserving all remaining doses for frontline workers, according to the CNA.
Chen Hsiu-hsi, the epidemiologist, said about 30% of Taiwan's medical workers had now been vaccinated. He is hopeful that number will reach 50% with the newly arrived 400,000 doses of the AstraZeneca vaccine.
The island's three coronavirus vaccine candidates went into clinical trials last August, five months after China and the US started testing their first vaccine candidates in humans.
While some health experts have blamed the Taiwanese government for not providing enough support for the island's drug companies to develop vaccines, it looks as if they are finally making headway.
On Tuesday, President Tsai Ing-wen said two Taiwanese vaccine candidates had reached the end of stage 2 clinical trials.
According to Tsai, the two vaccines developed by Taiwanese companies, Medigen Vaccine Biologics Corporation and United Biomedical, are expected to become available by the end of July, if they secure emergency use authorization next month.
Chen, the epidemiologist, said he was optimistic about Taiwan's domestically developed vaccines. "They have reported good results in stage 2 clinical trials, and it looks like they also respond well to different variants in a laboratory setting."
Until then, Chen said, Taiwan will need to rely on foreign vaccines to deal with the crisis -- but just not those from its closest neighbor with the largest supply.
www.cnn.com
台湾订了2千万剂疫苗，足够免疫43%人口，现在只到货70万，全部是AZ。
民众对疫苗表现出Low Interest。
台湾事实上的美国驻华大使萧说，由于台湾对疫苗的需求最初很低，她一直致力于帮助台北的邦交国获得疫苗。 但据CNA称，现在她正在努力确保台湾的订单能按时交付。
台北以台湾法律禁止进口供人类使用的中国疫苗为由，完全拒绝接受北京生产的中国疫苗。
陈说，现在台湾很需要依靠外国疫苗来应对这场危机-但不是那些来自其最近邻国的，供应量最大的疫苗。
Taiwan blames China for slowing down its access to Covid-19 vaccines. The reality is more complicated
By Nectar Gan and Eric Cheung, CNN
Updated 9:53 PM ET, Fri May 21, 2021
(CNN)As countries ravaged by the coronavirus rushed to vaccinate their populations earlier this year, there was little sense of urgency to get inoculated in Taiwan.
The island of 23 million people had recorded close to zero local infections for months, and demand for the vaccine was so low that only 1% of the population was vaccinated.
But in this pandemic things can change quickly. Today, Taiwan is battling its worst outbreak yet, reporting more than 1,000 new cases in the past week, and has a population that wants the vaccine -- but can't get it.
Now, the Taiwanese government is asking the United States for a share of the shots President Joe Biden plans to send abroad, as it waits for other deliveries to arrive.
But in theory, there could be a solution for Taiwan right on its doorstep: Chinese vaccines.
China has sent tens of millions doses of its domestically developed vaccines around the world. But tensions across the Taiwan Strait have run high since the pandemic, with Beijing blocking Taiwan's participation at the World Health Organization, courting Taipei's dwindling allies and ramping up military pressure on the self-governed island, which it considers part of its territory.
Taiwan was a Covid success story. Now it's fighting its biggest outbreak
Amid growing hostility and distrust, Taipei has outright refused to accept Chinese-made vaccines from Beijing, citing Taiwanese law banning the import of Chinese vaccines for human use. That's a move Beijing has blasted as tantamount to "sacrificing people's well-being for its own political interests."
Taipei doesn't see it that way, and has accused Beijing of blocking its supply, rather than trying to boost it.
On Wednesday, Presidential Office spokeswoman Kolas Yotaka said on Twitter: "Taiwan access to vaccines continues to be slowed down by Chinese interference, while they insist we buy Chinese made ones. If you really want to help please don't stand in the doorway, don't block up the hall."
Yotaka did not offer details on alleged Chinese interference. But in February, the island's Health Minister Chen Shih-chung revealed in a radio interview that Taiwan and BioNTech were about to sign a contract for 5 million vaccine doses in December, until the deal fell through due to "political pressure." While BioNTech has a distribution deal in greater China with the Shanghai-based firm Fosun Pharma, Beijing denies obstructing the Taiwan deal.
But as a war of words around vaccines rages on, the reality is Taiwan's slow vaccine rollout goes far deeper than geopolitical tensions with China.
Limited supplies
Taiwan has ordered 20 million vaccine doses -- enough to fully vaccinate 43% of its population. But, so far, only about 700,000 doses have arrived, and all are made by AstraZeneca.According to the island's official Central News Agency (CNA), Taiwan signed a deal with AstraZeneca last year to purchase 10 million doses of its vaccine. In March, 117,000 doses were finally shipped from a South Korean factory, becoming the first vaccines to arrive on the island.
Taiwan blames 'external forces' for blocking BioNTech vaccine deal. China says it had nothing to do with it
Taiwan also ordered 4.76 million doses through COVAX -- the global initiative backed by WHO to ensure equitable access to Covid-19 vaccines. The first batch of 199,200 shots arrived in early April, followed by a second delivery of 400,000 doses on Wednesday.
In February, Taiwan signed a contract for 5 million doses with US vaccine maker Moderna. The island's Central Epidemic Command Center said the shots were expected to be delivered this month. Last week, Taipei's top official in Washington said the shipment is now scheduled to arrive in June, CNA reported.
Hsiao Bi-khim, Taiwan's de-facto ambassador to the US, said as demand for vaccines in Taiwan was initially low, she had focused on helping Taipei's diplomatic allies secure vaccines. But now she is working to ensure Taiwan's orders are delivered on time, according to CNA.
Low interest
The Taiwanese government rolled out its vaccination program in late March, offering the first shots to medical staff. The program was later expanded to include police officers, care workers, the elderly and the military.In mid-April, it allowed people outside the government's priority list to be vaccinated at a cost of 600 New Taiwan dollars ($21) per shot.
But interest in taking the vaccine was low, as people had been enjoying a largely normal life for months, going to bars, restaurants, concerts and baseball games. There were also concerns about side effects, amid reports of blood clots in people who had received the AstraZeneca vaccine.
"Over the last 1.5 years, Taiwan did not experience a major outbreak, so many residents did not feel they were in any immediate danger," said Chen Hsiu-hsi, an epidemiology professor at National Taiwan University. "This is why not many people had the incentive to take Covid-19 vaccines."
But the spike in cases this month has caused alarm, prompting some residents to rush to get vaccinated. Before the latest batch from COVAX arrived on Wednesday, Taiwan had used up two-thirds of its 300,000-dose vaccine supply.
As supplies run short, the Taiwanese government has suspended the paid-for program, reserving all remaining doses for frontline workers, according to the CNA.
Chen Hsiu-hsi, the epidemiologist, said about 30% of Taiwan's medical workers had now been vaccinated. He is hopeful that number will reach 50% with the newly arrived 400,000 doses of the AstraZeneca vaccine.
Developing its own vaccines
When it comes to developing its own Covid-19 vaccine, Taiwan has lagged the efforts of the US, the UK, Germany, China and Russia.The island's three coronavirus vaccine candidates went into clinical trials last August, five months after China and the US started testing their first vaccine candidates in humans.
While some health experts have blamed the Taiwanese government for not providing enough support for the island's drug companies to develop vaccines, it looks as if they are finally making headway.
On Tuesday, President Tsai Ing-wen said two Taiwanese vaccine candidates had reached the end of stage 2 clinical trials.
According to Tsai, the two vaccines developed by Taiwanese companies, Medigen Vaccine Biologics Corporation and United Biomedical, are expected to become available by the end of July, if they secure emergency use authorization next month.
Chen, the epidemiologist, said he was optimistic about Taiwan's domestically developed vaccines. "They have reported good results in stage 2 clinical trials, and it looks like they also respond well to different variants in a laboratory setting."
Until then, Chen said, Taiwan will need to rely on foreign vaccines to deal with the crisis -- but just not those from its closest neighbor with the largest supply.
Taiwan blames China for slowing down its access to Covid-19 vaccines. The reality is more complicated | CNN
As countries ravaged by the coronavirus rushed to vaccinate their populations earlier this year, there was little sense of urgency to get inoculated in Taiwan.
辉瑞和复兴一样，是投资方，股东之一，德国的 BioNtech 才是开发商。
台湾不会不知道。
billwanhua
本站元老
- 注册
- 2005-07-07
- 消息
- 16,274
- 荣誉分数
- 5,277
- 声望点数
- 373
这个台湾节目说中国有没有阻挡国际给台湾疫苗，从19分钟开始。
其中还说出了一个很有趣的讨论，大陆说给疫苗，如果台湾说考虑接受，美国肯定怕马上先给台湾疫苗。台湾现政府完全意识形态办事，没有一点谈判技巧。怪大陆还不如自己检讨一下策略，一副好牌非要乱打。
最后编辑:
gocanoeing
本站元老
- 注册
- 2006-11-21
- 消息
- 16,426
- 荣誉分数
- 2,386
- 声望点数
- 373
據《彭博》報導，德國生技公司BioNTech在全球大部分地區都是跟美國輝瑞藥廠合作生產（Pfizer–BioNTech）疫苗，但中國復興製藥子公司上海復星醫藥於2020年3月同意向BioNTech支付8500萬美元（約新台幣24億元）的授權費及購買5000萬美元（約新台幣14億元）的BioNTech股份，取得BNT疫苗在中國及港澳台地區的代理權。而該公司與BioNTech合作的疫苗即為「復必泰」疫苗。
我國隨AZ疫苗開始施打，下批疫苗何時來台也被受關注。先前雖試圖與輝瑞直接簽約買BNT疫苗，但衛福部長陳時中3月29日坦言，目前沒有更多進展，雙方完成簽約、進而取得BNT疫苗的可能性已越來越小。
對此，復星醫藥執行長郭廣昌接受彭博採訪時宣稱，公司「有責任、有義務且有意願」提供大中華地區「最好」的疫苗，「當然包括台灣」。
彭博在報導中表示，即便北京當局一再向外界宣稱台灣是其領土「不可分割的一部分」，但相信台灣當局還是會自行與外國藥廠簽約，直言BNT疫苗儼然成為台海兩岸最新的角力來源。
news.ltn.com.tw
我國隨AZ疫苗開始施打，下批疫苗何時來台也被受關注。先前雖試圖與輝瑞直接簽約買BNT疫苗，但衛福部長陳時中3月29日坦言，目前沒有更多進展，雙方完成簽約、進而取得BNT疫苗的可能性已越來越小。
對此，復星醫藥執行長郭廣昌接受彭博採訪時宣稱，公司「有責任、有義務且有意願」提供大中華地區「最好」的疫苗，「當然包括台灣」。
彭博在報導中表示，即便北京當局一再向外界宣稱台灣是其領土「不可分割的一部分」，但相信台灣當局還是會自行與外國藥廠簽約，直言BNT疫苗儼然成為台海兩岸最新的角力來源。
輝瑞BNT疫苗無下文 中國代理商復星：願賣台灣復必泰！ - 政治 - 自由時報電子報
我國先前試圖直接向美國輝瑞藥廠簽約購買BNT武漢肺炎（新型冠狀病毒病，COVID-19）疫苗，但至今還未有下文。對此，取得BNT疫苗大中華地區代理權的上海復星醫藥週三（31日）表示，他們願意提供台灣「復必泰」（BNT162b2）疫苗。據《彭博》報導，德國生技公司BioNTech在全球大部分地區都是跟美國輝瑞藥廠合作生產（Pfizer–BioNTech）疫苗，但中國復興製藥子公司上海復星醫藥於2020年3月同意向BioNTech支付8500萬美元（約新台幣24億元）的授權費及購買5000萬美元（約新台幣14億元）的BioNTech股份，取得BNT疫苗在中國及港澳台地區的代理權。而該公司與B...
至少欧洲和东南亚的区域授权归 BioNTech 安排而不是 Pfizer
三立、自由时报此前一直是在黑 BioNTech 疫苗，鼓吹处于 II 期临床试验阶段的 “高端疫苗” (品牌) 和 AstraZeneca
三立、自由时报此前一直是在黑 BioNTech 疫苗，鼓吹处于 II 期临床试验阶段的 “高端疫苗” (品牌) 和 AstraZeneca
據《彭博》報導，德國生技公司BioNTech在全球大部分地區都是跟美國輝瑞藥廠合作生產（Pfizer–BioNTech）疫苗，但中國復興製藥子公司上海復星醫藥於2020年3月同意向BioNTech支付8500萬美元（約新台幣24億元）的授權費及購買5000萬美元（約新台幣14億元）的BioNTech股份，取得BNT疫苗在中國及港澳台地區的代理權。而該公司與BioNTech合作的疫苗即為「復必泰」疫苗。
我國隨AZ疫苗開始施打，下批疫苗何時來台也被受關注。先前雖試圖與輝瑞直接簽約買BNT疫苗，但衛福部長陳時中3月29日坦言，目前沒有更多進展，雙方完成簽約、進而取得BNT疫苗的可能性已越來越小。
對此，復星醫藥執行長郭廣昌接受彭博採訪時宣稱，公司「有責任、有義務且有意願」提供大中華地區「最好」的疫苗，「當然包括台灣」。
彭博在報導中表示，即便北京當局一再向外界宣稱台灣是其領土「不可分割的一部分」，但相信台灣當局還是會自行與外國藥廠簽約，直言BNT疫苗儼然成為台海兩岸最新的角力來源。
輝瑞BNT疫苗無下文 中國代理商復星：願賣台灣復必泰！ - 政治 - 自由時報電子報
我國先前試圖直接向美國輝瑞藥廠簽約購買BNT武漢肺炎（新型冠狀病毒病，COVID-19）疫苗，但至今還未有下文。對此，取得BNT疫苗大中華地區代理權的上海復星醫藥週三（31日）表示，他們願意提供台灣「復必泰」（BNT162b2）疫苗。據《彭博》報導，德國生技公司BioNTech在全球大部分地區都是跟美國輝瑞藥廠合作生產（Pfizer–BioNTech）疫苗，但中國復興製藥子公司上海復星醫藥於2020年3月同意向BioNTech支付8500萬美元（約新台幣24億元）的授權費及購買5000萬美元（約新台幣14億元）的BioNTech股份，取得BNT疫苗在中國及港澳台地區的代理權。而該公司與B...
最后编辑:
- 注册
- 2007-08-08
- 消息
- 8,866
- 荣誉分数
- 1,406
- 声望点数
- 373
土共国积极给台湾疫苗，就会刺激美国大方派送疫苗分给台湾，
土共是间接帮助台湾
土共是间接帮助台湾
- 注册
- 2007-08-08
- 消息
- 8,866
- 荣誉分数
- 1,406
- 声望点数
- 373
500 万剂 Moderna 中的 100 万剂，不知道会不会从六月下旬提前到上旬到货
大概可以分到 AstraZeneca 或者 Johnson & Johnson 的一部分
大概可以分到 AstraZeneca 或者 Johnson & Johnson 的一部分
